Article 13 Apr 2026 Class Action Pursued Over Infection Risks Linked To Endoscope Devices Canada Consumer
Article 12 Jan 2026 Class Action Pursued Concerning Safety Defects With GLP-1 Drugs Mounjaro, Trulicity, & Zepbound Canada Litigation
Article 07 Jan 2026 Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients Canada Healthcare
Article 02 Dec 2025 Ozempic, A Diabetes Drug Linked To Gastrointestinal Issues And Vision Loss, Approved To Treat Kidney Issues Canada Healthcare
Article 23 Oct 2024 New Warnings For Gastroparesis, Severe Stomach Problems Added To Popular GLP-1 Drugs Canada Healthcare
Article 11 Mar 2024 Canadians Who Spent Time At Camp Lejeune In Jacksonville, North Carolina May Be Eligible For Compensation Worldwide Litigation
Article 06 Nov 2023 Class Action Pursued For Canadians Alleging Harms From Ozempic, Semaglutide Drugs Canada Healthcare
Article 24 Oct 2023 Bard PowerPort Catheters: Device Failures Linked To Health Risks Canada Media & IT
Article 24 Aug 2023 Ozempic For Weight Loss? Know The Risks Of Off-Label Prescriptions Canada Healthcare
Article 10 Aug 2023 Bladder Drug Elmiron – Linked To Vision Loss, Macular Degeneration – Still Among Top Non-Patented Drugs In Canada Per 2023 Report Canada Healthcare
Article 27 Jul 2023 Xeljanz, Linked To Heart Attacks, Blood Clots, And Cancers – Is Now Approved To Treat Arthritis Of The Spine Canada Healthcare
Article 11 Jul 2023 Newly Released J&J Bankruptcy Plan For Compensating Talcum Powder Cancer Claims Includes Canadian Claims Canada Insolvency
Article 30 May 2023 Canadians Can Now Claim Under $20 Million OxyContin Class Actions Settlement Canada Litigation